PubMed Health⌕ Search

Biomedical subjects

A Maynard

Publications and source records attributed to A Maynard.

At least 91 records · Page 5Linked to original sources

A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries.

The purpose of this study was to estimate the costs and benefits of the use of recombinant human erythropoietin (epoetin) in the treatment of anaemia arising from chronic renal failure. A 5-nation study, using an identical research protocol, was carried out by groups in France, Germany, Italy, Spain and the UK to identify the costs of the use of epoetin, the resource savings generated by such treatment and the effects of this treatment on the quality of life of patients. The latter was measured using the Rosser matrix of disability-distress states. The results show that the use of epoetin can produce a competitive cost per quality-adjusted life-year (QALY) only in patients with serious incapacity. Use of epoetin in patients who are not transfusion dependent would be an expensive way of gaining health benefits, which would be achieved at considerable opportunity cost.

Anemia↗

Screening for patients at risk of alcohol related problems: the results of the York District Hospital Alcohol Study.

This study examined the feasibility of training medical and nursing staff in the use of a brief Alcohol Screening Questionnaire, which assists the early identification of patients who drink to excess. Over a two-year period 7,217 questionnaires were completed on patients admitted to York District General Hospital. Analysis showed the screening questionnaire to be a quick and reliable instrument, although the characteristics of the screener influenced its effectiveness. The results suggest that hospital staff require little training before they can effectively identify patients who drink to excess.

Alcoholism↗

Chaos has no victors.

Explore the source record for details and available documents.

Health Services Accessibility↗

Grasping the nettle.

Explore the source record for details and available documents.

Administrative Personnel↗

The design of future cost-benefit studies.

An economic evaluation is designed to prioritize expenditure, aid decision making, and inform medical audit. A good economic evaluation is explicit and clearly describes the alternative therapies to be evaluated. The evaluation takes into consideration the cost of each component and measures outcome in economic benefit and physical, social, and psychologic well-being. A variety of approaches can be used to assess quality of life, and a good economic evaluation will use a range of measures. Costs and outcomes of health care interventions typically accrue across time periods, and the analysis must allow for this. Similarly, data must answer the question; how much does it cost to identify one additional unit of benefit? Because all evaluations are imprecise both in cost and outcome, sensitivity analysis is needed to determine the effect that different assumptions have on the results.

Coronary Disease↗

Morbidity variation and RAWP.

STUDY OBJECTIVE: Resource allocations from the central government to the English health regions are determined by population levels adjusted by relative standardised mortality ratios (SMRs). The White Paper Working for Patients proposes that allocations should in future be based on capitation adjusted by some other measures of health. The aim of this paper was to investigate the effect of using morbidity data in the weighting algorithm instead of relative SMRs. DESIGN: Morbidity data were obtained from the Health and Lifestyle Survey, 1986. Three different measures of self reported morbidity were used (Long Standing Illness, Any Declared Condition, Any Handicap). Population weightings were calculated by national average bed use for these conditions and again for SMRs. SETTING: This was a national survey using data from all the English health regions. MAIN RESULTS: All three measures of morbidity showed a wider variation between regions than SMRs, and the weighted populations showed a correspondingly wide variation (approximately double that obtained when using SMRs). CONCLUSION: The weighting of populations will be crucial in determining resource allocations to budget holders, whether in the hospital or primary care sector. However without a prior agreement on what counts as "need", the choice of these alternative measures will be arbitrary.

Health Care Rationing↗

A half baked review?

Explore the source record for details and available documents.

Economic Competition↗